{"id": "hfksbg", "title": "KPTI - Multiple Analysts predicting the stock value to double?", "selftext": "KPTI\u2019s new drug therapy received FDA approval. Most analysts have upgraded their price targets (according to MarketBeat).\n\nCurrent Price: $18.5-19 |\nConsensus Price Target: $32-35\n\nSources:\n\nhttps://www.marketbeat.com/stocks/NASDAQ/KPTI/price-target/\n\nhttps://www.google.com/amp/s/m.investing.com/news/wedbush-stick-to-their-hold-rating-for-karyopharm-therapeutics-2210696%3fampMode=1\n\nThoughts?", "created_utc": 1593086111.0, "permalink": "/r/wallstreetbets/comments/hfksbg/kpti_multiple_analysts_predicting_the_stock_value/", "is_self": true}